TAKEDA PHARMA A/S: Financial statements 2018
CVR: 16406899
Source: annual report 2018, Danish Business Authority
01/04/2017 – 31/03/2018
TAKEDA PHARMA A/S (CVR 16406899) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 1,782,339,000 and a net result of DKK 595,839,000 compared with DKK -102,646,000 the year before. That is an increase of 3.1% compared with the year before. The profit margin was 33.4%. Equity in the 2018 report amounted to DKK 100,534,993,000. The solvency ratio was 99.7%. The company had 197 employees in the financial year.
- Revenue
- DKK 1,782,339,000
- Gross Profit
- DKK 712,119,000
- Profit/Loss
- DKK 595,839,000
- Equity
- DKK 100,534,993,000
- Total Assets
- DKK 100,882,065,000
- Employees
- 197
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 1.8 mia. | 712.1 mio. | 595.8 mio. | 100.5 mia. | 197 |
| 2017 | 1.7 mia. | 626 mio. | -102.6 mio. | 99.9 mia. | 305 |
| 2016 | 1.7 mia. | 212.5 mio. | 25.3 mia. | 100.2 mia. | 488 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout TAKEDA PHARMA A/S
TAKEDA PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1984. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NYCOMED DANMARK ApS and NYCOMED DANMARK A/S. The management consists of Enor Cerimagic. The board consists of Koki Sato (chair), Enor Cerimagic, Jesper Lindahl and Malene Kelstrup. The company is owned by Takeda Pharmaceuticals International AG. The company has 79 employees (2026). In 2026, the company reported revenue of DKK 1,112,753,000 and a net result of DKK 88,641,000 compared with DKK 12,162,000 the year before. Equity in the 2026 report amounted to DKK 456,501,000.